Scintigrafie skeletu a její role mezi zobrazovacími metodamiReview articles

E. Hoffmannová

Clin Osteol 2016; 21(1): 3-9

Sklerostin při chronickém onemocnění a selhání ledvin: literární přehled současných poznatkůReview articles

E. Vykoukalová, S. Dusilová Sulková, R. Šafránek, J. Vávrová, M. Kalousová, J. Kohoutová, A. Malá, M. Ryba, L. Pavlíková, V. Palička

Clin Osteol 2016; 21(1): 10-17

Sclerostin has nega porosis. Chronic kidney disease (CKD) is associated with calcium, phosphorus and vitamin D metabolism disorders and it is obligatory con­ nected with renal osteopathy and cardiovascular system disorders (chronic kidney disease - mineral and bone disorder, CKD-MBD). According to recen cular cross-talk). Serum sclerostin concentration increases in the course of chronic kidney disease. Not only missing renal elimination, but also bone metabolism change, i.e. sclerostin secretion change, could be the reason. Contrary to the expectations, correlation between bone den­ sity and sclerostin serum concentration is rather positive than negative,...

Osteoporóza a diabetes mellitus - klinické aspektyReview articles

M. Žurek, P. Horák

Clin Osteol 2016; 21(1): 18-23

Regeneration of the long bone after implantation into its defect of osteoplastic material «Cerabone®»Informations

A. Korenkov

Clin Osteol 2016; 21(1): 24-27

News from around the worldLiterature

Clin Osteol 2016; 21(1): 38-41

Report from the Committee meeting of SMOSNews

Clin Osteol 2016; 21(1): 42